Fundraising Fox

DCVC Bio

Palo Alto

Fox Verdict
Sign up to see your fit

Fund manager profile

DCVC Bio is a venture fund manager based in Palo Alto. SEC filings show 1 venture fund on record, most recently DCVC Bio III, L.P. ($400M offering) filed September 2023.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
Palo Alto, US
Tracked investments
3

What they invest in

from 3 of 3 portfolio companies

Biotech ×2Medical Devices ×2AgTech ×1AI & Machine Learning ×1Deep Tech ×1Digital Health ×1Hardware ×1

HQs:United States×6

Investments · 3 tracked

founders shown can be your intro path
AgZenagzen.com

AgZen develops real-time monitoring technology for crop spraying, analyzing droplet behavior to help growers and agricultural equipment manufacturers optimize application efficiency. The company serves farmers, ag equipment companies, and researchers in the agriculture industry.

AgTechAI & Machine LearningHardware

Vishnu JayaprakashKripa VaranasiMaher Damak

nChroma Bionchromabio.com

nChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications. The company works with academic founders and institutional investors focused on advancing gene therapy treatments.

BiotechDeep TechMedical Devices

Luke Gilbert, PhDKeith Joung, MD, PhDDavid Liu, PhDAngelo Lombardo, PhD

Umoja Biopharma, Inc.umoja-biopharma.com

Umoja Biopharma develops in vivo CAR T cell therapies for cancer treatment using its VivoVec platform, which generates CAR T cells directly in patients' bodies. The company operates its own manufacturing facility to produce these cancer immunotherapies.

BiotechDigital HealthMedical Devices

Board seats · per SEC filings · 6

what is this? ⓘ
Avicenna Biosciences, Inc.SEC filing

$70.7K raise · filed Oct 2025 · via John Hamer

ELO LIFE SYSTEMS, INC.SEC filing

$25M raise · filed Jan 2024 · via Kiersten Todd Stead

MycoWorks, Inc.SEC filing

$63.1M raise · filed Jun 2023 · via Kiersten Stead

Empirico Inc.SEC filing

$55.2M raise · filed Mar 2023 · via John Hamer

Unlearn.ai, Inc.SEC filing

$50M raise · filed Apr 2022 · via John Ryan Hamer

Epsilon Holdings, Inc.SEC filing

$24.5M raise · filed Dec 2021 · via Kiersten Stead

Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Frequently asked questions

Where is DCVC Bio located?
DCVC Bio is headquartered in Palo Alto, US.

Featured in lists